Modella AI’s generative AI co-pilot PathChat receives FDA breakthrough device designation
This recognition underscores PathChat DX’s potential to transform diagnostic workflows and improve patient outcomes in pathology.
This recognition underscores PathChat DX’s potential to transform diagnostic workflows and improve patient outcomes in pathology.
Bio-Rad leads investment to support the launch of ColoSense® to advance diagnostic innovations for inflammatory bowel disease
With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship
Partnership seeks to improve patient outcomes and experiences through novel digital and diagnostic solutions
Discover how Mayo Clinic Digital Pathology, powered by NVIDIA and Aignostics, is leveraging AI and vast datasets to revolutionize diagnostics, accelerate medical breakthroughs, and improve patient outcomes worldwide.
MOBILion's SLIM tech reaches 100 publications, showcasing its innovation and impact in advancing separation science
This award has been for ImpediMed's support in the Point-of-Care Bioimpedance Spectroscopy Industry
Healthcare thought-leaders share how high-sensitivity troponin immunoassays are changing the face of cardiac care
Enhancing breast cancer diagnostics with precision, efficiency, and improved grading consistency for better patient outcomes
This innovative technology aims to improve acute care outcomes, particularly for myocardial infarction diagnosis.
A new, more sustainable AI model recognizes visual scenes by mirroring brain processes, opening doors for applications in medical diagnostics, drug discovery and beyond
Burnout and other factors are hitting clinical laboratories hard, what’s driving the shortfall of lab techs, and what can be done to reverse the trend?
Advancing early Alzheimer's diagnosis with scalable, ultra-sensitive technology
Critical study will evaluate clinical feasibility of multi-cancer detection screening tests and begin to determine how best to incorporate them into the standard of care
Roche Diagnostics leadership answers questions around cobas® mass spectrometry solution launch
AI-powered solution to enhance diagnostic efficiency, streamline clinical trials, and improve patient outcomes across global pathology networks
Guest editorial by Dr. Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems, Senior Vice President, Roche
This partnership is revolutionizing bladder cancer diagnostics with seamless access to non-invasive genomic testing and enhanced clinical efficiency
CLINICAL24 supporter, the Global Sepsis Alliance, advances global efforts to combat sepsis through leadership, advocacy, and community engagement
Join the CEO of MicrosensDx, Simon Walker, for a Q&A surrounding his collaboration with The Mayr Group at Imperial College London to develop a new sepsis test
Find out how CLINICAL24 supporter, UK Sepsis Trust is addressing workforce challenges and promoting early sepsis diagnosis in healthcare
Take the survey and submit a guest editorial